Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN.

× No keyword cloud information.

9 in total

1. Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function.

Authors: Sirigiri Divijendra Natha Reddy; Suresh B Pakala; Poonam R Molli; Neil Sahni; Narasimha Kumar Karanam; Prakriti Mudvari; Rakesh Kumar
Journal: J Biol Chem Date: 2012-06-14 Impact factor: 5.157

2. Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors: William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal: Cell Cycle Date: 2012-11-16 Impact factor: 4.534

Review 3. Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets.

Authors: Yoshihiro Ito; Jonathan R Hart; Peter K Vogt
Journal: Expert Opin Ther Targets Date: 2018-09-24 Impact factor: 6.902

4. TAT-protein blockade during ischemia/reperfusion reveals critical role for p85 PI3K-PTEN interaction in cardiomyocyte injury.

Authors: Xiangdong Zhu; Zuo-Hui Shao; Changqing Li; Jing Li; Qiang Zhong; Jonathan Learoyd; Angelo Meliton; Lucille Meliton; Alan R Leff; Terry L Vanden Hoek
Journal: PLoS One Date: 2014-04-21 Impact factor: 3.240

5. Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β.

Authors: Yoshihiro Ito; Peter K Vogt; Jonathan R Hart
Journal: Oncotarget Date: 2017-08-03

Review 6. Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors: James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal: Oncotarget Date: 2012-09

7. Spherical cell shape of FLC-4 cell, a human hepatoma cell, enhances hepatocyte-specific function and suppresses tumor phenotype through the integration of mRNA-microRNA interaction.

Authors: Thomas Laurent; Yutaro Kataoka; Satoru Kobayashi; Misaki Ando; Seishi Nagamori; Hiroaki Oda
Journal: Biol Open Date: 2012-08-08 Impact factor: 2.422

8. Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.

Authors: Paul Mellor; Jeremy D S Marshall; Xuan Ruan; Dielle E Whitecross; Rebecca L Ross; Margaret A Knowles; Stanley A Moore; Deborah H Anderson
Journal: Sci Rep Date: 2018-05-08 Impact factor: 4.379

Review 9. Class IA PI3K regulatory subunits: p110-independent roles and structures.

Authors: Millie Fox; Helen R Mott; Darerca Owen
Journal: Biochem Soc Trans Date: 2020-08-28 Impact factor: 5.407

9 in total